全国范围内儿童患者大环内酯类耐药肺炎支原体感染的监测。
Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.
机构信息
Department of Pediatrics, Kawasaki Medical School, Okayama, Japan.
出版信息
Antimicrob Agents Chemother. 2013 Aug;57(8):4046-9. doi: 10.1128/AAC.00663-13. Epub 2013 May 28.
Abstract
We conducted nationwide surveillance to investigate regional differences in macrolide-resistant (MR) Mycoplasma pneumoniae strains in Japan. The prevalence of MR M. pneumoniae in pediatric patients gradually increased between 2008 and 2012. Although regional differences were observed, high levels of MR genes were detected in all seven surveillance areas throughout Japan and ranged in prevalence from 50% to 93%. These regional differences were closely related to the previous administration of macrolides.
摘要
我们进行了全国范围的监测，以调查日本肺炎支原体耐药（MR）株的地区差异。在 2008 年至 2012 年期间，儿科患者中 MR 肺炎支原体的流行率逐渐增加。虽然观察到了地区差异，但在日本所有七个监测地区均检测到高水平的 MR 基因，流行率从 50%到 93%不等。这些地区差异与先前使用大环内酯类抗生素密切相关。
相似文献
1
Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.全国范围内儿童患者大环内酯类耐药肺炎支原体感染的监测。
Antimicrob Agents Chemother. 2013 Aug;57(8):4046-9. doi: 10.1128/AAC.00663-13. Epub 2013 May 28.
2
Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.日本福冈大环内酯类耐药肺炎支原体感染的基因和细胞因子谱分析。
BMC Infect Dis. 2013 Dec 16;13:591. doi: 10.1186/1471-2334-13-591.
3
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.日本 2008-2015 年耐大环内酯类肺炎支原体感染。
Emerg Infect Dis. 2017 Oct;23(10):1703-1706. doi: 10.3201/eid2310.170106.
4
Regional Differences in Prevalence of Macrolide Resistance among Pediatric Mycoplasma pneumoniae Infections in Hokkaido, Japan.日本北海道小儿肺炎支原体感染中大环内酯类耐药率的地区差异
Jpn J Infect Dis. 2016 May 20;69(3):186-90. doi: 10.7883/yoken.JJID.2015.054. Epub 2015 Jul 10.
5
[Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].[中国北京成年社区获得性肺炎患者肺炎支原体大环内酯类耐药性调查]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Dec;36(12):954-8.
6
Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.成人社区获得性肺炎中对大环内酯类耐药的肺炎支原体
Int J Antimicrob Agents. 2010 Oct;36(4):384-5. doi: 10.1016/j.ijantimicag.2010.06.009. Epub 2010 Jul 31.
7
Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.青少年社区获得性肺炎中耐大环内酯类肺炎支原体。
BMC Infect Dis. 2012 May 31;12:126. doi: 10.1186/1471-2334-12-126.
8
First Detection and Characterization of Macrolide-Resistant from People with Community-Acquired Pneumonia in Iran.伊朗社区获得性肺炎患者中大环内酯类耐药 的首次检测和特征描述。
Microb Drug Resist. 2020 Mar;26(3):245-250. doi: 10.1089/mdr.2019.0223. Epub 2019 Sep 23.
9
Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.儿童肺炎支原体新出现的大环内酯类耐药性：耐药菌株的检测与特征分析
Pediatr Infect Dis J. 2009 Aug;28(8):693-6. doi: 10.1097/INF.0b013e31819e3f7a.
10
Multilocus Sequence Typing of Mycoplasma pneumoniae, Japan, 2002-2016.2002-2016 年日本肺炎支原体多位点序列分型。
Emerg Infect Dis. 2018 Oct;24(10):1895-1901. doi: 10.3201/eid2410.171194.
引用本文的文献
1
Clinical features and risk factors for severe macrolide-resistant mycoplasma pneumoniae pneumonia induced by 23 S rRNA A2063G mutation: a retrospective observational study.23S rRNA A2063G突变所致重症大环内酯类耐药肺炎支原体肺炎的临床特征及危险因素：一项回顾性观察研究
Eur J Clin Microbiol Infect Dis. 2025 Jul 17. doi: 10.1007/s10096-025-05215-4.
2
The efficacy of azithromycin combined with seven types of Chinese medicine injections in the treatment of pneumonia in children: a systematic review and Bayesian network meta-analysis.阿奇霉素联合七种中药注射剂治疗儿童肺炎的疗效：一项系统评价和贝叶斯网络Meta分析
Front Pharmacol. 2024 Sep 24;15:1378445. doi: 10.3389/fphar.2024.1378445. eCollection 2024.
3
Clinical Manifestations, Macrolide Resistance, and Treatment Utilization Trends of Pneumonia in Children and Adolescents in South Korea.韩国儿童和青少年肺炎的临床表现、大环内酯类耐药性及治疗利用趋势
Microorganisms. 2024 Aug 31;12(9):1806. doi: 10.3390/microorganisms12091806.
4
Clinical efficacy of macrolide antibiotics in mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23 S rRNA gene in pediatric patients.大环内酯类抗生素对23S rRNA基因携带大环内酯类耐药突变的小儿支原体肺炎的临床疗效
BMC Infect Dis. 2024 Jul 31;24(1):758. doi: 10.1186/s12879-024-09612-6.
5
Novel Knowledge of Macrolide Resistance in by Azithromycin Exposure.阿奇霉素暴露导致大环内酯类耐药的新认识。 （注：你提供的原文表述不太完整，推测可能是这样翻译，你可检查下原文是否准确完整）
Microorganisms. 2024 Jan 21;12(1):218. doi: 10.3390/microorganisms12010218.
6
Novel mechanisms of macrolide resistance revealed by selection and genome analysis in .通过筛选和基因组分析揭示 中的大环内酯类耐药新机制。
Front Cell Infect Microbiol. 2023 May 22;13:1186017. doi: 10.3389/fcimb.2023.1186017. eCollection 2023.
7
Atypical Pathogens in Adult Community-Acquired Pneumonia and Implications for Empiric Antibiotic Treatment: A Narrative Review.成人社区获得性肺炎中的非典型病原体及其对经验性抗生素治疗的影响：叙述性综述
Microorganisms. 2022 Nov 24;10(12):2326. doi: 10.3390/microorganisms10122326.
8
Risk of Dental Discoloration and Enamel Dysplasia in Children Exposed to Tetracycline and Its Derivatives.儿童暴露于四环素及其衍生物中牙齿变色和釉质发育不全的风险。
Yonsei Med J. 2022 Dec;63(12):1113-1120. doi: 10.3349/ymj.2022.0388.
9
Delivering macrolide antibiotics to heal a broken heart - And other inflammatory conditions.将大环内酯类抗生素用于治疗破碎的心——以及其他炎症性疾病。
Adv Drug Deliv Rev. 2022 May;184:114252. doi: 10.1016/j.addr.2022.114252. Epub 2022 Mar 30.
10
Clinical Significance of Pleural Effusion in Pneumonia in Children.儿童肺炎中胸腔积液的临床意义
Pathogens. 2021 Aug 25;10(9):1075. doi: 10.3390/pathogens10091075.
本文引用的文献
1
Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.青少年社区获得性肺炎中耐大环内酯类肺炎支原体。
BMC Infect Dis. 2012 May 31;12:126. doi: 10.1186/1471-2334-12-126.
2
Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011.2010 年和 2011 年丹麦肺炎支原体感染的流行。
Euro Surveill. 2012 Feb 2;17(5):20073. doi: 10.2807/ese.17.05.20073-en.
3
Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States.美国中部地区大环内酯类耐药肺炎支原体感染率上升。
Pediatr Infect Dis J. 2012 Apr;31(4):409-0. doi: 10.1097/INF.0b013e318247f3e0.
4
Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.大环内酯类抗生素治疗儿童肺炎支原体肺炎中基因决定的大环内酯类耐药的临床疗效。
Respirology. 2012 Feb;17(2):354-62. doi: 10.1111/j.1440-1843.2011.02102.x.
5
Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.以色列 2010 年肺炎支原体大环内酯类耐药性。
Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.
6
Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia.《2007年日本儿童呼吸道传染病管理指南》，重点关注肺炎。
Pediatr Int. 2011 Apr;53(2):264-76. doi: 10.1111/j.1442-200x.2010.03316.x.
7
Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children.儿童肺炎支原体感染爆发期间大环内酯类耐药株的出现。
J Antimicrob Chemother. 2011 Apr;66(4):734-7. doi: 10.1093/jac/dkr003. Epub 2011 Jan 31.
8
Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults.成人肺炎支原体肺炎快速诊断方法的临床应用潜力。
Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):439-46. doi: 10.1007/s10096-010-1107-8.
9
Chronic macrolide therapy in inflammatory airways diseases.慢性大环内酯类药物治疗在炎症性气道疾病中的应用。
Chest. 2010 Nov;138(5):1202-12. doi: 10.1378/chest.10-0196.
10
Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.大环内酯类耐药肺炎支原体：分离株的特征和社区获得性肺炎的临床方面。
J Infect Chemother. 2010 Apr;16(2):78-86. doi: 10.1007/s10156-009-0021-4. Epub 2010 Jan 22.
Zotero 插件